Fusion Antibodies (LON:FAB) Trading Up 9.4% – Here’s What Happened

Fusion Antibodies plc (LON:FAB)’s share price traded up 9.4% on Monday . The stock traded as high as GBX 9.50 ($0.12) and last traded at GBX 9.30 ($0.11). 643,059 shares changed hands during trading, a decline of 73% from the average session volume of 2,371,604 shares. The stock had previously closed at GBX 8.50 ($0.10).

Fusion Antibodies Stock Up 2.7 %

The firm has a market cap of £8.96 million, a P/E ratio of -235.00 and a beta of 0.49. The company has a fifty day simple moving average of GBX 6.54 and a 200-day simple moving average of GBX 4.64. The company has a quick ratio of 2.36, a current ratio of 3.87 and a debt-to-equity ratio of 2.40.

Fusion Antibodies (LON:FAB) last announced its quarterly earnings results on Tuesday, November 19th. The company reported GBX (0.80) (($0.01)) EPS for the quarter. Fusion Antibodies had a negative return on equity of 152.68% and a negative net margin of 195.95%. On average, equities analysts anticipate that Fusion Antibodies plc will post -129.9999875 earnings per share for the current year.

Fusion Antibodies Company Profile

Fusion is a Belfast based contract research organisation (“CRO”) providing a range of antibody engineering services for the development of antibodies for both therapeutic drug and diagnostic applications.

The Company’s ordinary shares were admitted to trading on AIM on 18 December 2017. Fusion provides a broad range of services in antibody generation, development, production, characterisation and optimisation.